Request Demo
Last update 28 Nov 2025
Live Attenuated freeze-dried Influenza Vaccine(Changchun BCHT Biotechnology)
Last update 28 Nov 2025
Overview
Basic Info
Drug Type Live attenuated vaccine, Prophylactic vaccine |
Synonyms Influenza Vaccine，Live，Nasal，Freeze-dried, 感雾 |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhaseApproved |
First Approval Date China (02 Apr 2020), |
Regulation- |
Login to view timeline
Related
10
Clinical Trials associated with Live Attenuated freeze-dried Influenza Vaccine(Changchun BCHT Biotechnology)NCT06280144
Multi-center, Randomized, Double-blind, Placebo-controlled Trial of a Live Attenuated Influenza Vaccine in People Aged 3-17
CTR20220581
多中心、随机、双盲、阳性对照和安慰剂对照的三臂设计，评价鼻喷流感减毒活疫苗在3~59周岁健康人群中的免疫原性和安全性的Ⅱ期临床试验
[Translation] A phase II clinical trial with a multicenter, randomized, double-blind, positive-controlled and placebo-controlled three-arm design to evaluate the immunogenicity and safety of nasal spray live attenuated influenza vaccine in healthy people aged 3 to 59 years
CTR20212179
单中心、随机、双盲、安慰剂对照评价鼻喷流感减毒活疫苗在3~59周岁健康人群中的安全性和免疫原性的Ⅰ期临床试验
[Translation] A single-center, randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of a live attenuated nasal influenza vaccine in healthy people aged 3 to 59 years
100 Clinical Results associated with Live Attenuated freeze-dried Influenza Vaccine(Changchun BCHT Biotechnology)
Login to view more data
100 Translational Medicine associated with Live Attenuated freeze-dried Influenza Vaccine(Changchun BCHT Biotechnology)
Login to view more data
100 Patents (Medical) associated with Live Attenuated freeze-dried Influenza Vaccine(Changchun BCHT Biotechnology)
Login to view more data
100 Deals associated with Live Attenuated freeze-dried Influenza Vaccine(Changchun BCHT Biotechnology)
Login to view more data
External Link
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| - | - | - |
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Influenza, Human | China | 02 Apr 2020 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| influenza A subtype H3N2 infection | Phase 2 | China | 18 Mar 2022 | |
| Influenza B virus infection | Phase 2 | China | 18 Mar 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free